Antioxidants and other pharmacological treatments for Friedreich ataxia

Mary Kearney, Richard Orrell, Michael Fahey, Massimo Pandolfo

Research output: Contribution to journalArticleResearchpeer-review

33 Citations (Scopus)

Abstract

Friedreich ataxia is a rare inherited autosomal recessive neurological disorder, characterised initially by unsteadiness in standing and walking, slowly progressing to wheelchair dependency usually in the late teens or early twenties. It is associated with slurred speech, scoliosis and pes cavus. Heart abnormalities cause premature death in 60 to 80 of people with the disorder. There is no easily defined clinical or biochemical marker and no known treatment. This is the first update of a review published in 2009.
Original languageEnglish
Pages (from-to)1 - 27
Number of pages27
JournalCochrane Database of Systematic Reviews
Volume2012
Issue numberArt. No. CD007791
DOIs
Publication statusPublished - 2012

Cite this

Kearney, Mary ; Orrell, Richard ; Fahey, Michael ; Pandolfo, Massimo. / Antioxidants and other pharmacological treatments for Friedreich ataxia. In: Cochrane Database of Systematic Reviews. 2012 ; Vol. 2012, No. Art. No. CD007791. pp. 1 - 27.
@article{c1d9c72926a7433cb1053e71d46f2d96,
title = "Antioxidants and other pharmacological treatments for Friedreich ataxia",
abstract = "Friedreich ataxia is a rare inherited autosomal recessive neurological disorder, characterised initially by unsteadiness in standing and walking, slowly progressing to wheelchair dependency usually in the late teens or early twenties. It is associated with slurred speech, scoliosis and pes cavus. Heart abnormalities cause premature death in 60 to 80 of people with the disorder. There is no easily defined clinical or biochemical marker and no known treatment. This is the first update of a review published in 2009.",
author = "Mary Kearney and Richard Orrell and Michael Fahey and Massimo Pandolfo",
year = "2012",
doi = "10.1002/14651858.CD007791.pub3",
language = "English",
volume = "2012",
pages = "1 -- 27",
journal = "Cochrane Database of Systematic Reviews",
issn = "1469-493X",
publisher = "John Wiley & Sons",
number = "Art. No. CD007791",

}

Antioxidants and other pharmacological treatments for Friedreich ataxia. / Kearney, Mary; Orrell, Richard; Fahey, Michael; Pandolfo, Massimo.

In: Cochrane Database of Systematic Reviews, Vol. 2012, No. Art. No. CD007791, 2012, p. 1 - 27.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Antioxidants and other pharmacological treatments for Friedreich ataxia

AU - Kearney, Mary

AU - Orrell, Richard

AU - Fahey, Michael

AU - Pandolfo, Massimo

PY - 2012

Y1 - 2012

N2 - Friedreich ataxia is a rare inherited autosomal recessive neurological disorder, characterised initially by unsteadiness in standing and walking, slowly progressing to wheelchair dependency usually in the late teens or early twenties. It is associated with slurred speech, scoliosis and pes cavus. Heart abnormalities cause premature death in 60 to 80 of people with the disorder. There is no easily defined clinical or biochemical marker and no known treatment. This is the first update of a review published in 2009.

AB - Friedreich ataxia is a rare inherited autosomal recessive neurological disorder, characterised initially by unsteadiness in standing and walking, slowly progressing to wheelchair dependency usually in the late teens or early twenties. It is associated with slurred speech, scoliosis and pes cavus. Heart abnormalities cause premature death in 60 to 80 of people with the disorder. There is no easily defined clinical or biochemical marker and no known treatment. This is the first update of a review published in 2009.

UR - http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD007791.pub3/pdf

U2 - 10.1002/14651858.CD007791.pub3

DO - 10.1002/14651858.CD007791.pub3

M3 - Article

VL - 2012

SP - 1

EP - 27

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

SN - 1469-493X

IS - Art. No. CD007791

ER -